South Staffordshire and Shropshire Healthcare NHS Foundation Trust ECT Care Pathway (prescriber to complete except where otherwise

Size: px
Start display at page:

Download "South Staffordshire and Shropshire Healthcare NHS Foundation Trust ECT Care Pathway (prescriber to complete except where otherwise"

Transcription

1 South Staffordshire and Shropshire Healthcare NHS Foundation Trust ECT Care Pathway (prescriber to complete except where otherwise Patient Name of Birth Patient Number Consultant Pathway Commenced. P..... /... /... Instructions Regarding the Use of the ECT Pathway The ECT pathway is designed to guide clinicians through the process based on best practice. This pathway reflects ECTAS standards, NICE Guidance and the Mental Health Act. All sections should be completed. It should be read in conjunction with the trust ECT policy. The pathway will begin on decision to prescribe ECT and finish six months after the course of ECT finishes. The audit tool should completed at the end of the course The pathway forms part of the patient s record and should be contained within the patient s case notes. 1. Instructions to ECT s Regarding Medication The current drugs card should accompany the patient to the ECT Department for all treatment Please refer to the Royal College of Psychiatrist s ECT Handbook 2 nd edition (available in full text at RCPsych website) for information regarding the impact of medications e.g. Anticonvulsants, Benzodiazepines, SSRI s and Lithium on ECT / seizure threshold and duration The Royal College recommends that the patient s existing drug regime is assessed prior to the course and that a consistent prescription regime is followed on treatment days where possible (ECTAS ) Non-psychiatric medication should be given routinely with a sip of water up to an hour before ECT (Omit hypoglycaemic agents in diabetics until after treatment) Page 9 of 65

2 2. Patient Information(prescriber to complete) Patient s Name Patient No: Gender Male Female of Birth Ward Consultant (Please print) Ethnicity (Please circle) A White or white British B White Irish C Any other White background CM White Traveller CN White Gypsy D Mixed White and Black Caribbean E Mixed White and Black African F Mixed White and Asian G Any other mixed background H Asian or Asian British Indian J Asian or Asian British Pakistani K Asian or Asian British Bangladeshi L Any other Asian background M Black or Black British Caribbean N Black or Black British African P Any other Black background R Chinese S Any other ethnic group Diagnosis ICD-10 Code:. Patient Status In-patient Out-patient Please clearly state the indication for ECT: NB : ECT will not be administered unless the indication is clearly stated Previous courses of ECT (give dates, indications, location and outcome for each course) s Indication Location Outcome NICE Indications: - Please tick which of the following conditions apply to your patient: (There should be at least one tick in both sections) Severe depressive disorder Yes No Severe or prolonged manic episode Yes No Catatonia Yes No and Where an adequate trial of other treatment options proven ineffective Yes No And / or the condition is potentially life threatening Yes No Page 10 of 65

3 Surname Forename ECT Policy/C/YEL/cm/10/v3.0 P Number 3. ECT prescribed outside NICE Guidance ( to complete) (NB If the treatment is within NICE guidance and patient consenting 2 nd opinion is not required please continue with pathway) When prescribing outside of NICE guidance for informal / consenting patients please obtain a second opinion from a consultant colleague / SOAD Consultant s opinion: Indication for Treatment outside guidance Justification / evidence base What would happen if ECT is not given? Signature of Consultant Print Name 2 nd Opinion: (Trust Guidance should be followed) Confirmation Signature of Doctor Designation Print Name Page 11 of 65

4 Surname Forename ECT Policy/C/YEL/cm/10/v3.0 P Number 4.Consent Form (Consultant or team doctor to complete) Procedure to be administered: A course of bilateral / unilateral electroconvulsive therapy up to a maximum of 12 treatments (Delete as applicable) I have explained the procedure to the patient. In particular, I have explained: The intended benefits: Improvement of depression Other (please specify).. Serious / frequently occurring risks: Memory loss (possibly permanent) Post treatment confusion and transient side-effects: Headache & Muscle aches Nausea Muzzy-headedness Fatigue I confirm that I have explained to the patient the nature, purpose, likely effects and adverse effects of this treatment and possible alternatives, including no treatment, and that the patient has been provided with the royal college of Psychiatrists ECT information sheet. I confirm that in my opinion the benefits of ECT outweigh the risks (Bi / Uni Lateral explained). I confirm I have explained that this procedure will involve: General Anaesthesia & Muscle Relaxation Signed: : Name: (PRINT) Job Title: Contact details (if patient wishes to discuss options later) (via secretary) Statement of Interpreter (where appropriate) I have interpreted the information above to the patient to the best of my ability and in a way in which I believe she / he can understand Signed: : Name: (PRINT) Statement of advocate or carer (where appropriate) (please circle) I have interpreted the information above to the patient to the best of my ability and in a way in which I believe she / he can understand Signed: : Name: (PRINT) Designation Advocate / Carer Page 12 of 65

5 Surname Forename ECT Policy/C/YEL/cm/10/v3.0 P Number Statement of patient Patient s Name NHS or P Number Please read this form carefully. You should already have your own copy of the information booklet that describes the intended benefits and frequently occurring risks of ECT. If not, you will be offered a copy now. If you have any further questions, do ask we are here to help you. You have the right to change your mind at any time, including after you have signed this form. I agree to the procedure and course of treatment described on this form I understand that you cannot give me a guarantee that a particular person will perform the procedure. The person will, however, have appropriate experience. I understand that I will have the opportunity to discuss the details of anaesthesia with an anaesthetist before the procedure, unless the urgency of my situation prevents this. I understand that any procedure in addition to those described on this form will be carried out only if it is necessary to save my life or to prevent serious harm to my health. I have been told about additional procedures that may become necessary during my treatment. I have listed below any procedures that I do not wish to be carried out without further discussion. Procedures that I do not wish to be carried out without further discussion: Patient s Signature: : Name: (PRINT) A witness should sign below if the patient is unable to sign but has indicated his or her consent: Witness Signature: : Name: (PRINT) Important Notes: (tick if applicable) See also advance directive / living will (e.g. Jehovah s Witness form) Page 13 of 65

6 Surname Forename P Number Confirmation of Consent To be completed by a health professional each time the patient attends for the procedure, ensuring the patient has signed the form in advance of treatment - any changes to MHA / consent status should be documented. On behalf of the team treating the patient, I have confirmed with the patient that she / he has no further questions and wishes the procedure to go ahead. I have explained that the patient may withdraw consent at any time of Procedure: Signed: Name: (PRINT) MHA status : Job Title: of Procedure: Signed: Name: (PRINT) MHA status : Job Title: of Procedure: Signed: Name: (PRINT) MHA status : Job Title: of Procedure: Signed: Name: (PRINT) MHA status : Job Title: of Procedure: Signed: Name: (PRINT) of Procedure: Signed: Name: (PRINT) MHA status : Job Title: MHA status : Job Title: of Procedure: Signed: Name: (PRINT) MHA status : Job Title: of Procedure: Signed: Name: (PRINT) MHA status : Job Title: of Procedure: Signed: Name: (PRINT) MHA status : Job Title: Page 14 of 65

7 Surname Forename P Number Confirmation of Consent To be completed by a health professional each time the patient attends for the procedure, ensuring the patient has signed the form in advance of treatment - any changes to MHA / consent status should be documented. On behalf of the team treating the patient, I have confirmed with the patient that she / he has no further questions and wishes the procedure to go ahead. I have explained that the patient may withdraw consent at any time of Procedure: Signed: Name: (PRINT) MHA status : Job Title: of Procedure: Signed: Name: (PRINT) MHA status : Job Title: of Procedure: Signed: Name: (PRINT) MHA status : Job Title: of Procedure: Signed: Name: (PRINT) MHA status : Job Title: of Procedure: Signed: Name: (PRINT) MHA status : Job Title: of Procedure: Signed: Name: (PRINT) MHA status : Job Title: of Procedure: Signed: Name: (PRINT) MHA status : Job Title: of Procedure: MHA status Signed: : Name: (PRINT) Job Title: Surname Forename P Number Page 15 of 65

8 5. Physical Status (To be completed by a doctor from the prescribing team) A Full Physical needs to be completed within seven days of commencing ECT Please check patient records for date of last full physical Relevant Physical Illness / Condition of last full physical (within last 7 days) Yes No Yes No MI Adrenal disease Angina Asthma / bronchitis Cardiac failure CVA Hypertension Epilepsy Ischemic Heart Disease Hiatus hernia Anaemia Hepatitis B/Jaundice/Liver disease Thyroid disease Sickle cell trait / disease Diabetes Pregnancy Details: Dental problems e.g. crowns, dentures, loose teeth Communication problems e.g. deafness Other factors that increase the risk of treatment? Details: Details: Details: Alcohol intake Details: Is patient a smoker Details (no. per day): Bleeding/bruising easily Details: Other relevant medical history and diagnoses and previous drug side effects (including serious illness) Known Allergies (including plasters) Please clarify with G.P. before prescribing ECT Details of previous operation record and any problems with anaesthesia Page 16 of 65

9 Surname Forename ECT Policy/C/YEL/cm/10/v3.0 P Number Please record any clinically indicated or important pre ECT physical investigations (please refer to ECT policy available on website) Test Comments / Results Full Blood Count (all patients) U&E and LFTs (all patients) Urine for blood, protein, sugar (all patients) Pulse rate and rhythm (all patients) Blood Pressure (all patients) Weight (all patients) Chest X-Ray (where clinically indicated. If in doubt discuss with anaesthetist) ECG (male smokers over 45 yrs of age and anyone else over 50) Other Signature and name of team doctor completing this section : 6. Pre ECT Anaesthetic Assessment Please specify ASA (American Society of Anaesthetist) Grade: I II III IV V Definitions: I Fit and Well II Minor medical problem(s) not effecting lifestyle (no impairment of motor activity e.g. can walk as far as desired) III Significant medical problem(s) affecting lifestyle (e.g. impairs motor activity) IV Serious medical problem(s) with constant threat to life V Moribund; surgery etc. Comments: Signature and Name of Anaesthetist confirming that the patient is fit for ECT treatment : Page 17 of 65

10 7. ECT Prescription ( to complete all sections) Not more than two ECT s to be prescribed at one time. to review weekly at least. Prescription valid for two weeks. If unilateral ECT is prescribed, right unilateral will be given if not otherwise specified. should refer to the Royal College ECT Handbook Second Edition for advice on laterality Patient Name: P number: of Medical Review: Response to treatment in this course thus far: (please circle) N/A Too early to say Responding adequately Inadequate response Increase Dose Side Effects to treatment in this course thus far: (please circle) N/A Headaches Aches Fatigue Anxiety Confusion Memory Loss Legal / Consent Status The patient is: (please tick one box and circle relevant MH section) Over 18, Informal, Capicitous and Consenting (consent form for ECT completed) Over 18, Informal, Incapacitous, Not objecting, No advance refusal or objection from LPA, C of P / deputy and family / advocate consulted (treatment prescribed in best interests under mental capacity act ) Over 18, Detained (section 2,3,36,37,38,45A, 47 or 48), Capacitous & Consenting (MHA Form T4 - certificate of consent to treatment [ECT] completed) Over 18, Detained (Section 2,3 36,37, 38,45A, 47 or 48), Capacitous but Refusing Emergencies only (Section 62 Form conditions a or b completed) Over 18, Detained (Section 2,3, 36,37, 38,45A, 47 or 48), Incapacitous & no advance refusal or objection from LPA, C of P / deputy (MHA Form T6 Certificate of second opinion or in emergency Section 62 Form conditions a or b completed) Over18, Detained - Section 2,3, 36,37, 38,45A or 48, Incapacitous but either advance refusal or objection of LPA, C of P / deputy (Section 62 Form conditions a or b completed) Other scenarios eg under 18s / CTOs etc please specify..and seek advice from MHA dept & ECT dept ECT Session Number Type of ECT bilateral / Unilateral. Where appropriate Check Patient s preference (Consent form) Comments e.g. re Dose ECT Prescription prescription Written Signature of Name of (Print) Grade of (must be Consultant, Associate Specialist, ST4 and above) Bilateral Page 18 of 65

11 7. ECT Prescription ( to complete all sections) Not more than two ECT s to be prescribed at one time. to review weekly at least. Prescription valid for two weeks. If unilateral ECT is prescribed, right unilateral will be given if not otherwise specified. should refer to the Royal College ECT Handbook Second Edition for advice on laterality Patient Name: P number: of Medical Review: Response to treatment in this course thus far: (please circle) N/A Too early to say Responding adequately Inadequate response Increase Dose Side Effects to treatment in this course thus far: (please circle) N/A Headaches Aches Fatigue Anxiety Confusion Memory Loss Legal / Consent Status The patient is: (please tick one box and circle relevant MH section) Over 18, Informal, Capicitous and Consenting (consent form for ECT completed) Over 18, Informal, Incapacitous, Not objecting, No advance refusal or objection from LPA, C of P / deputy and family / advocate consulted (treatment prescribed in best interests under mental capacity act ) Over 18, Detained (section 2,3,36,37,38,45A, 47 or 48), Capacitous & Consenting (MHA Form T4 - certificate of consent to treatment [ECT] completed) Over 18, Detained (Section 2,3 36,37, 38,45A, 47 or 48), Capacitous but Refusing Emergencies only (Section 62 Form conditions a or b completed) Over 18, Detained (Section 2,3, 36,37, 38,45A, 47 or 48), Incapacitous & no advance refusal or objection from LPA, C of P / deputy (MHA Form T6 Certificate of second opinion or in emergency Section 62 Form conditions a or b completed) Over18, Detained - Section 2,3, 36,37, 38,45A or 48, Incapacitous but either advance refusal or objection of LPA, C of P / deputy (Section 62 Form conditions a or b completed) Other scenarios eg under 18s / CTOs etc please specify..and seek advice from MHA dept & ECT dept ECT Session Number Type of ECT bilateral / Unilateral. Where appropriate Check Patient s preference (Consent form) Comments e.g. re Dose ECT Prescription prescription Written Signature of Name of (Print) Grade of (must be Consultant, Associate Specialist, ST4 and above) Bilateral Page 19 of 65

12 7. ECT Prescription ( to complete all sections) Not more than two ECT s to be prescribed at one time. to review weekly at least. Prescription valid for two weeks. If unilateral ECT is prescribed, right unilateral will be given if not otherwise specified. should refer to the Royal College ECT Handbook Second Edition for advice on laterality Patient Name: P number: of Medical Review: Response to treatment in this course thus far: (please circle) N/A Too early to say Responding adequately Inadequate response Increase Dose Side Effects to treatment in this course thus far: (please circle) N/A Headaches Aches Fatigue Anxiety Confusion Memory Loss Legal / Consent Status The patient is: (please tick one box and circle relevant MH section) Over 18, Informal, Capicitous and Consenting (consent form for ECT completed) Over 18, Informal, Incapacitous, Not objecting, No advance refusal or objection from LPA, C of P / deputy and family / advocate consulted (treatment prescribed in best interests under mental capacity act ) Over 18, Detained (section 2,3,36,37,38,45A, 47 or 48), Capacitous & Consenting (MHA Form T4 - certificate of consent to treatment [ECT] completed) Over 18, Detained (Section 2,3 36,37, 38,45A, 47 or 48), Capacitous but Refusing Emergencies only (Section 62 Form conditions a or b completed) Over 18, Detained (Section 2,3, 36,37, 38,45A, 47 or 48), Incapacitous & no advance refusal or objection from LPA, C of P / deputy (MHA Form T6 Certificate of second opinion or in emergency Section 62 Form conditions a or b completed) Over18, Detained - Section 2,3, 36,37, 38,45A or 48, Incapacitous but either advance refusal or objection of LPA, C of P / deputy (Section 62 Form conditions a or b completed) Other scenarios eg under 18s / CTOs etc please specify..and seek advice from MHA dept & ECT dept ECT Session Number Type of ECT bilateral / Unilateral. Where appropriate Check Patient s preference (Consent form) Comments e.g. re Dose ECT Prescription prescription Written Signature of Name of (Print) Grade of (must be Consultant, Associate Specialist, ST4 and above) Bilateral Page 20 of 65

13 7. ECT Prescription ( to complete all sections) Not more than two ECT s to be prescribed at one time. to review weekly at least. Prescription valid for two weeks. If unilateral ECT is prescribed, right unilateral will be given if not otherwise specified. should refer to the Royal College ECT Handbook Second Edition for advice on laterality Patient Name: P number: of Medical Review: Response to treatment in this course thus far: (please circle) N/A Too early to say Responding adequately Inadequate response Increase Dose Side Effects to treatment in this course thus far: (please circle) N/A Headaches Aches Fatigue Anxiety Confusion Memory Loss Legal / Consent Status The patient is: (please tick one box and circle relevant MH section) Over 18, Informal, Capicitous and Consenting (consent form for ECT completed) Over 18, Informal, Incapacitous, Not objecting, No advance refusal or objection from LPA, C of P / deputy and family / advocate consulted (treatment prescribed in best interests under mental capacity act ) Over 18, Detained (section 2,3,36,37,38,45A, 47 or 48), Capacitous & Consenting (MHA Form T4 - certificate of consent to treatment [ECT] completed) Over 18, Detained (Section 2,3 36,37, 38,45A, 47 or 48), Capacitous but Refusing Emergencies only (Section 62 Form conditions a or b completed) Over 18, Detained (Section 2,3, 36,37, 38,45A, 47 or 48), Incapacitous & no advance refusal or objection from LPA, C of P / deputy (MHA Form T6 Certificate of second opinion or in emergency Section 62 Form conditions a or b completed) Over18, Detained - Section 2,3, 36,37, 38,45A or 48, Incapacitous but either advance refusal or objection of LPA, C of P / deputy (Section 62 Form conditions a or b completed) Other scenarios eg under 18s / CTOs etc please specify..and seek advice from MHA dept & ECT dept ECT Session Number Type of ECT bilateral / Unilateral. Where appropriate Check Patient s preference (Consent form) Comments e.g. re Dose ECT Prescription prescription Written Signature of Name of (Print) Grade of (must be Consultant, Associate Specialist, ST4 and above) Bilateral Page 21 of 65

14 7. ECT Prescription ( to complete all sections) Not more than two ECT s to be prescribed at one time. to review weekly at least. Prescription valid for two weeks. If unilateral ECT is prescribed, right unilateral will be given if not otherwise specified. should refer to the Royal College ECT Handbook Second Edition for advice on laterality Patient Name: P number: of Medical Review: Response to treatment in this course thus far: (please circle) N/A Too early to say Responding adequately Inadequate response Increase Dose Side Effects to treatment in this course thus far: (please circle) N/A Headaches Aches Fatigue Anxiety Confusion Memory Loss Legal / Consent Status The patient is: (please tick one box and circle relevant MH section) Over 18, Informal, Capicitous and Consenting (consent form for ECT completed) Over 18, Informal, Incapacitous, Not objecting, No advance refusal or objection from LPA, C of P / deputy and family / advocate consulted (treatment prescribed in best interests under mental capacity act ) Over 18, Detained (section 2,3,36,37,38,45A, 47 or 48), Capacitous & Consenting (MHA Form T4 - certificate of consent to treatment [ECT] completed) Over 18, Detained (Section 2,3 36,37, 38,45A, 47 or 48), Capacitous but Refusing Emergencies only (Section 62 Form conditions a or b completed) Over 18, Detained (Section 2,3, 36,37, 38,45A, 47 or 48), Incapacitous & no advance refusal or objection from LPA, C of P / deputy (MHA Form T6 Certificate of second opinion or in emergency Section 62 Form conditions a or b completed) Over18, Detained - Section 2,3, 36,37, 38,45A or 48, Incapacitous but either advance refusal or objection of LPA, C of P / deputy (Section 62 Form conditions a or b completed) Other scenarios eg under 18s / CTOs etc please specify..and seek advice from MHA dept & ECT dept ECT Session Number Type of ECT bilateral / Unilateral. Where appropriate Check Patient s preference (Consent form) Comments e.g. re Dose ECT Prescription prescription Written Signature of Name of (Print) Grade of (must be Consultant, Associate Specialist, ST4 and above) Bilateral Page 22 of 65

15 7. ECT Prescription ( to complete all sections) Not more than two ECT s to be prescribed at one time. to review weekly at least. Prescription valid for two weeks. If unilateral ECT is prescribed, right unilateral will be given if not otherwise specified. should refer to the Royal College ECT Handbook Second Edition for advice on laterality Patient Name: P number: of Medical Review: Response to treatment in this course thus far: (please circle) N/A Too early to say Responding adequately Inadequate response Increase Dose Side Effects to treatment in this course thus far: (please circle) N/A Headaches Aches Fatigue Anxiety Confusion Memory Loss Legal / Consent Status The patient is: (please tick one box and circle relevant MH section) Over 18, Informal, Capicitous and Consenting (consent form for ECT completed) Over 18, Informal, Incapacitous, Not objecting, No advance refusal or objection from LPA, C of P / deputy and family / advocate consulted (treatment prescribed in best interests under mental capacity act ) Over 18, Detained (section 2,3,36,37,38,45A, 47 or 48), Capacitous & Consenting (MHA Form T4 - certificate of consent to treatment [ECT] completed) Over 18, Detained (Section 2,3 36,37, 38,45A, 47 or 48), Capacitous but Refusing Emergencies only (Section 62 Form conditions a or b completed) Over 18, Detained (Section 2,3, 36,37, 38,45A, 47 or 48), Incapacitous & no advance refusal or objection from LPA, C of P / deputy (MHA Form T6 Certificate of second opinion or in emergency Section 62 Form conditions a or b completed) Over18, Detained - Section 2,3, 36,37, 38,45A or 48, Incapacitous but either advance refusal or objection of LPA, C of P / deputy (Section 62 Form conditions a or b completed) Other scenarios eg under 18s / CTOs etc please specify..and seek advice from MHA dept & ECT dept ECT Session Number Type of ECT bilateral / Unilateral. Where appropriate Check Patient s preference (Consent form) Comments e.g. re Dose ECT Prescription prescription Written Signature of Name of (Print) Grade of (must be Consultant, Associate Specialist, ST4 and above) Bilateral Page 23 of 65

16 7. ECT Prescription ( to complete all sections) Not more than two ECT s to be prescribed at one time. to review weekly at least. Prescription valid for two weeks. If unilateral ECT is prescribed, right unilateral will be given if not otherwise specified. should refer to the Royal College ECT Handbook Second Edition for advice on laterality Patient Name: P number: of Medical Review: Response to treatment in this course thus far: (please circle) N/A Too early to say Responding adequately Inadequate response Increase Dose Side Effects to treatment in this course thus far: (please circle) N/A Headaches Aches Fatigue Anxiety Confusion Memory Loss Legal / Consent Status The patient is: (please tick one box and circle relevant MH section) Over 18, Informal, Capicitous and Consenting (consent form for ECT completed) Over 18, Informal, Incapacitous, Not objecting, No advance refusal or objection from LPA, C of P / deputy and family / advocate consulted (treatment prescribed in best interests under mental capacity act ) Over 18, Detained (section 2,3,36,37,38,45A, 47 or 48), Capacitous & Consenting (MHA Form T4 - certificate of consent to treatment [ECT] completed) Over 18, Detained (Section 2,3 36,37, 38,45A, 47 or 48), Capacitous but Refusing Emergencies only (Section 62 Form conditions a or b completed) Over 18, Detained (Section 2,3, 36,37, 38,45A, 47 or 48), Incapacitous & no advance refusal or objection from LPA, C of P / deputy (MHA Form T6 Certificate of second opinion or in emergency Section 62 Form conditions a or b completed) Over18, Detained - Section 2,3, 36,37, 38,45A or 48, Incapacitous but either advance refusal or objection of LPA, C of P / deputy (Section 62 Form conditions a or b completed) Other scenarios eg under 18s / CTOs etc please specify..and seek advice from MHA dept & ECT dept ECT Session Number Type of ECT bilateral / Unilateral. Where appropriate Check Patient s preference (Consent form) Comments e.g. re Dose ECT Prescription prescription Written Signature of Name of (Print) Grade of (must be Consultant, Associate Specialist, ST4 and above) Bilateral Page 24 of 65

17 7. ECT Prescription ( to complete all sections) Not more than two ECT s to be prescribed at one time. to review weekly at least. Prescription valid for two weeks. If unilateral ECT is prescribed, right unilateral will be given if not otherwise specified. should refer to the Royal College ECT Handbook Second Edition for advice on laterality Patient Name: P number: of Medical Review: Response to treatment in this course thus far: (please circle) N/A Too early to say Responding adequately Inadequate response Increase Dose Side Effects to treatment in this course thus far: (please circle) N/A Headaches Aches Fatigue Anxiety Confusion Memory Loss Legal / Consent Status The patient is: (please tick one box and circle relevant MH section) Over 18, Informal, Capicitous and Consenting (consent form for ECT completed) Over 18, Informal, Incapacitous, Not objecting, No advance refusal or objection from LPA, C of P / deputy and family / advocate consulted (treatment prescribed in best interests under mental capacity act ) Over 18, Detained (section 2,3,36,37,38,45A, 47 or 48), Capacitous & Consenting (MHA Form T4 - certificate of consent to treatment [ECT] completed) Over 18, Detained (Section 2,3 36,37, 38,45A, 47 or 48), Capacitous but Refusing Emergencies only (Section 62 Form conditions a or b completed) Over 18, Detained (Section 2,3, 36,37, 38,45A, 47 or 48), Incapacitous & no advance refusal or objection from LPA, C of P / deputy (MHA Form T6 Certificate of second opinion or in emergency Section 62 Form conditions a or b completed) Over18, Detained - Section 2,3, 36,37, 38,45A or 48, Incapacitous but either advance refusal or objection of LPA, C of P / deputy (Section 62 Form conditions a or b completed) Other scenarios eg under 18s / CTOs etc please specify..and seek advice from MHA dept & ECT dept ECT Session Number Type of ECT bilateral / Unilateral. Where appropriate Check Patient s preference (Consent form) Comments e.g. re Dose ECT Prescription prescription Written Signature of Name of (Print) Grade of (must be Consultant, Associate Specialist, ST4 and above) Bilateral Page 25 of 65

18 7. ECT Prescription ( to complete all sections) Not more than two ECT s to be prescribed at one time. to review weekly at least. Prescription valid for two weeks. If unilateral ECT is prescribed, right unilateral will be given if not otherwise specified. should refer to the Royal College ECT Handbook Second Edition for advice on laterality Patient Name: P number: of Medical Review: Response to treatment in this course thus far: (please circle) N/A Too early to say Responding adequately Inadequate response Increase Dose Side Effects to treatment in this course thus far: (please circle) N/A Headaches Aches Fatigue Anxiety Confusion Memory Loss Legal / Consent Status The patient is: (please tick one box and circle relevant MH section) Over 18, Informal, Capicitous and Consenting (consent form for ECT completed) Over 18, Informal, Incapacitous, Not objecting, No advance refusal or objection from LPA, C of P / deputy and family / advocate consulted (treatment prescribed in best interests under mental capacity act ) Over 18, Detained (section 2,3,36,37,38,45A, 47 or 48), Capacitous & Consenting (MHA Form T4 - certificate of consent to treatment [ECT] completed) Over 18, Detained (Section 2,3 36,37, 38,45A, 47 or 48), Capacitous but Refusing Emergencies only (Section 62 Form conditions a or b completed) Over 18, Detained (Section 2,3, 36,37, 38,45A, 47 or 48), Incapacitous & no advance refusal or objection from LPA, C of P / deputy (MHA Form T6 Certificate of second opinion or in emergency Section 62 Form conditions a or b completed) Over18, Detained - Section 2,3, 36,37, 38,45A or 48, Incapacitous but either advance refusal or objection of LPA, C of P / deputy (Section 62 Form conditions a or b completed) Other scenarios eg under 18s / CTOs etc please specify..and seek advice from MHA dept & ECT dept ECT Session Number Type of ECT bilateral / Unilateral. Where appropriate Check Patient s preference (Consent form) Comments e.g. re Dose ECT Prescription prescription Written Signature of Name of (Print) Grade of (must be Consultant, Associate Specialist, ST4 and above) Bilateral Page 26 of 65

19 7. ECT Prescription ( to complete all sections) Not more than two ECT s to be prescribed at one time. to review weekly at least. Prescription valid for two weeks. If unilateral ECT is prescribed, right unilateral will be given if not otherwise specified. should refer to the Royal College ECT Handbook Second Edition for advice on laterality Patient Name: P number: of Medical Review: Response to treatment in this course thus far: (please circle) N/A Too early to say Responding adequately Inadequate response Increase Dose Side Effects to treatment in this course thus far: (please circle) N/A Headaches Aches Fatigue Anxiety Confusion Memory Loss Legal / Consent Status The patient is: (please tick one box and circle relevant MH section) Over 18, Informal, Capicitous and Consenting (consent form for ECT completed) Over 18, Informal, Incapacitous, Not objecting, No advance refusal or objection from LPA, C of P / deputy and family / advocate consulted (treatment prescribed in best interests under mental capacity act ) Over 18, Detained (section 2,3,36,37,38,45A, 47 or 48), Capacitous & Consenting (MHA Form T4 - certificate of consent to treatment [ECT] completed) Over 18, Detained (Section 2,3 36,37, 38,45A, 47 or 48), Capacitous but Refusing Emergencies only (Section 62 Form conditions a or b completed) Over 18, Detained (Section 2,3, 36,37, 38,45A, 47 or 48), Incapacitous & no advance refusal or objection from LPA, C of P / deputy (MHA Form T6 Certificate of second opinion or in emergency Section 62 Form conditions a or b completed) Over18, Detained - Section 2,3, 36,37, 38,45A or 48, Incapacitous but either advance refusal or objection of LPA, C of P / deputy (Section 62 Form conditions a or b completed) Other scenarios eg under 18s / CTOs etc please specify..and seek advice from MHA dept & ECT dept ECT Session Number Type of ECT bilateral / Unilateral. Where appropriate Check Patient s preference (Consent form) Comments e.g. re Dose ECT Prescription prescription Written Signature of Name of (Print) Grade of (must be Consultant, Associate Specialist, ST4 and above) Bilateral Page 27 of 65

20 7. ECT Prescription ( to complete all sections) Not more than two ECT s to be prescribed at one time. to review weekly at least. Prescription valid for two weeks. If unilateral ECT is prescribed, right unilateral will be given if not otherwise specified. should refer to the Royal College ECT Handbook Second Edition for advice on laterality Patient Name: P number: of Medical Review: Response to treatment in this course thus far: (please circle) N/A Too early to say Responding adequately Inadequate response Increase Dose Side Effects to treatment in this course thus far: (please circle) N/A Headaches Aches Fatigue Anxiety Confusion Memory Loss Legal / Consent Status The patient is: (please tick one box and circle relevant MH section) Over 18, Informal, Capicitous and Consenting (consent form for ECT completed) Over 18, Informal, Incapacitous, Not objecting, No advance refusal or objection from LPA, C of P / deputy and family / advocate consulted (treatment prescribed in best interests under mental capacity act ) Over 18, Detained (section 2,3,36,37,38,45A, 47 or 48), Capacitous & Consenting (MHA Form T4 - certificate of consent to treatment [ECT] completed) Over 18, Detained (Section 2,3 36,37, 38,45A, 47 or 48), Capacitous but Refusing Emergencies only (Section 62 Form conditions a or b completed) Over 18, Detained (Section 2,3, 36,37, 38,45A, 47 or 48), Incapacitous & no advance refusal or objection from LPA, C of P / deputy (MHA Form T6 Certificate of second opinion or in emergency Section 62 Form conditions a or b completed) Over18, Detained - Section 2,3, 36,37, 38,45A or 48, Incapacitous but either advance refusal or objection of LPA, C of P / deputy (Section 62 Form conditions a or b completed) Other scenarios eg under 18s / CTOs etc please specify..and seek advice from MHA dept & ECT dept ECT Session Number Type of ECT bilateral / Unilateral. Where appropriate Check Patient s preference (Consent form) Comments e.g. re Dose ECT Prescription prescription Written Signature of Name of (Print) Grade of (must be Consultant, Associate Specialist, ST4 and above) Bilateral Page 28 of 65

21 7. ECT Prescription ( to complete all sections) Not more than two ECT s to be prescribed at one time. to review weekly at least. Prescription valid for two weeks. If unilateral ECT is prescribed, right unilateral will be given if not otherwise specified. should refer to the Royal College ECT Handbook Second Edition for advice on laterality Patient Name: P number: of Medical Review: Response to treatment in this course thus far: (please circle) N/A Too early to say Responding adequately Inadequate response Increase Dose Side Effects to treatment in this course thus far: (please circle) N/A Headaches Aches Fatigue Anxiety Confusion Memory Loss Legal / Consent Status The patient is: (please tick one box and circle relevant MH section) Over 18, Informal, Capicitous and Consenting (consent form for ECT completed) Over 18, Informal, Incapacitous, Not objecting, No advance refusal or objection from LPA, C of P / deputy and family / advocate consulted (treatment prescribed in best interests under mental capacity act ) Over 18, Detained (section 2,3,36,37,38,45A, 47 or 48), Capacitous & Consenting (MHA Form T4 - certificate of consent to treatment [ECT] completed) Over 18, Detained (Section 2,3 36,37, 38,45A, 47 or 48), Capacitous but Refusing Emergencies only (Section 62 Form conditions a or b completed) Over 18, Detained (Section 2,3, 36,37, 38,45A, 47 or 48), Incapacitous & no advance refusal or objection from LPA, C of P / deputy (MHA Form T6 Certificate of second opinion or in emergency Section 62 Form conditions a or b completed) Over18, Detained - Section 2,3, 36,37, 38,45A or 48, Incapacitous but either advance refusal or objection of LPA, C of P / deputy (Section 62 Form conditions a or b completed) Other scenarios eg under 18s / CTOs etc please specify..and seek advice from MHA dept & ECT dept ECT Session Number Type of ECT bilateral / Unilateral. Where appropriate Check Patient s preference (Consent form) Comments e.g. re Dose ECT Prescription prescription Written Signature of Name of (Print) Grade of (must be Consultant, Associate Specialist, ST4 and above) Bilateral Page 29 of 65

22 Surname Forename ECT Policy/C/YEL/cm/10/v3.0 P Number This section should be completed by a doctor from the prescribing team. Cognitive Functioning must be completed before ECT treatment commences and at 3 and 6 months post completion of course of ECT 9. Cognitive Functioning 1. Orientation What is today s day / date / month / year / season? Where are we? Town / city / county / country / building / floor? 2. Registration Name 3 common objects e.g. apple, chair, ball Ask the patient to repeat all three Repeat until all three are remembered. Number of trials needed: 3. Attention and Calculation Start from 100 and keep subtracting 7 Stop after 5 answers: (93, 86, 79, 72, 65) OR Spell the word WORLD backwards (DLROW) 4. Recall Repeat the three words I asked you to say earlier. 5. Language Naming: Show a watch and pencil and ask the patient to name them. Repeating: Repeat the following no ifs, ands, or buts. Reading: Show the sentence overleaf (Close Your Eyes) Read the sentence and do what it says Pre ECT Patient Score 3 mths 6 mths post post Maximum Points Write: a short sentence on your own. 1 Three stage command: Take a piece of paper in your right hand, fold it in half and place it on 3 the floor 6. Construction Copy this diagram (see next page) 1 Total MMS Score: Is there evidence of autobiographical memory loss? If yes give details in medical notes 8. Other ongoing subjective side effects. If yes give details in medical notes 9. Symptomatic Response e.g. good / poor etc Signed Name Page 30 of 65

23 Surname Forename P Number 9a Cognitive Functioning This section provides a baseline to the nursing assessment post ECT and should be completed as soon as possible before the commencement of ECT by the ward nursing team Baseline Question Comments/Response Can the patient walk in a straight line or are they tending to veer off to one side? Do they seem to be fully aware of their surroundings on both sides of them? Are they being clumsy, not noticing things to one side or bumping into things, perhaps missing the chair slightly when they sit? Has the patient complained of nausea? Has the patient complained of headaches? Has the patient complained of any aches or pains? Is the patient agitated? The name of the school the patient went to: What year did the patient get married? (or the date of some major personal event if not married): The ages of the patients children (or the age of some loved still living person if no living offspring): What are the names of your neighbours/or close friend? Has the person manipulated the cutlery in the usual way, using both knife and fork and positioning them normally on either side of the plate? Has the person been able to locate all items on the table easily? Has the person seemed to be aware of people sitting to their left and right equally? Has the person left food on just one side of the plate? Have they been able to manoeuvre their way around the ward and/or bedroom easily or have they seemed clumsy? Completed by Page 31 of 65

24 Surname Forename P Number 11. Nursing Checklist for ECT Patient Ward Nurse ECT Nurse To re-check and attend to items To complete items 1-13 by (yes), x (no), R (refused) or N/a (not applicable) Does patient have / wear :- please circle Dentures Yes or No Capped teeth Yes or No Hearing Aid Yes or No Spectacles Yes or No Contact lenses Yes or No 1. Patients identity confirmed 2. Correct case notes and prescription record 3. ECT record complete and in case notes 4. ECT nurse informed of any abnormalities a) Consent form complete OR 5. b) MHA documentation complete and in case notes 6. Consent reaffirmed by Patient (see Section 4) 7. Relevant investigation results in case notes (CXR, ECG, bloods) Session a) Blood pressure b) Pulse c) Temperature d) resps e) BM stix/blood glucose check immediately prior to each treatment for diabetics Has the patient passed urine (time)? When did patient last ear or drink (time)? 11. Has make up been removed? Hair shampooed night before and not wearing hair lacquer, gel etc? Jewellery and hairpins removed, documented and properly stored? *Anaesthetist informed of any abnormalities? *Artificial eyes / contact lenses removed documented and properly stored? *Electrode site prepared? 17. *Dentures removed documented and properly stored? 18. *Hearing aid / spectacles removed documented and properly stored? Initials (Ward Nurse) Page 32 of 65

25 Initials (ECT Nurse) Page 33 of 65

26 ECT Page 34 of 65

27 Page 35 of 65

28 and Start Time Surname Forename P Number 14. Recovery Nursing Observation Record Where changes to baseline observations have been observed please inform medical team for further advice. Checked with anaesthet ist re any problems T BP P SaO2 Resp Rec Time Rec BP Comments Signature Page 36 of 65

29 Surname Forename P Number ECT Poli 15. Ward Nursing Observation Checklist Post ECT Please indicate Correct / positive responses by patient with and incorrect / adverse / negative responses with Any negative / adverse responses should be discussed with Consultant prior to next ECT Treatment. Provide initials, tick and time in box Session Number Temperature 1 hour post treatment Temperature 3 hour post treatment Pulse Rate (bpm) 1 hour post treatment Pulse Rate (bpm) 3 hour post treatment Blood Pressure 1 hour post treatment Blood Pressure 3 hour post treatment Post Treatment Observations Respiration 1 hour post treatment Respiration 3 hour post treatment 1.1 Do you know where you are? 1. Ask 2. Watch for 3. Assess 1.2 Do you know what has happened so far today? 1.3 Do you know what time of day it is? 1.4 What is today s date? 2.1 Can they walk in a straight line or are they tending to veer off to one side? 2.2 Do they seem to be fully aware of their surroundings on both sides of them 2.3 Are they being clumsy, not noticing things to one side or bumping into things, perhaps missing the chair slightly when they sit? 3.1 Are you feeling sick? 3.2 Do you have a headache? 3.3 Do you have any aches or pains? 3.4 Is the patient agitated? 3.5 Does the patient seem fully alert? To be performed approximately 3 hours after treatment Page 37 of 65

30 Surname Forename P Number Session Number continued Temperature 1 hour post treatment Temperature 3 hour post treatment Pulse Rate (bpm) 1 hour post treatment Pulse Rate (bpm) 3 hour post treatment Blood Pressure 1 hour post treatment Blood Pressure 3 hour post treatment Post Treatment Observations Respiration 1 hour post treatment Respiration 3 hour post treatment 1.1 Do you know where you are? 1. Ask 2. Watch for 3. Assess 1.2 Do you know what has happened so far today? 1.3 Do you know what time of day it is? 1.4 What is today s date? 2.1 Can they walk in a straight line or are they tending to veer off to one side? 2.2 Do they seem to be fully aware of their surroundings on both sides of them 2.3 Are they being clumsy, not noticing things to one side or bumping into things, perhaps missing the chair slightly when they sit? 3.1 Are you feeling sick? 3.2 Do you have a headache? 3.3 Do you have any aches or pains? 3.4 Is the patient agitated? 3.5 Does the patient seem fully alert? To be performed approximately 3 hours after treatment Page 38 of 65

31 What is your home address? 4.2 What school did you go to? What year did you get married? (or the date of some major personal event if not married) How old is your son/daughter? (or the age of some loved still living person if no living offspring) What are the names of your neighbours? Has the person manipulated the cutlery in the usual way, using both knife and fork and positioning them normally on either side of the plate? Has the person been able to locate all items on the table easily? Has the person seemed to be aware of people sitting to their left and right equally? Has the person left food on just one side of the plate? Have they been able to manoeuvre their way around the ward and/or bedroom easily or have they seemed clumsy? Page 39 of Next Day following treatment 5. Sensory Awareness Ask the questions as above and also observe carefully the person s behaviour at table and while washing: 4. Autobiographical 6. Assess Surname Forename P Number 6.1 Has the person returned to a normal level of wakefulness?

32 Surname Forename P Number ECT 16a. Discharge Protocol for Day Patients In addition to any other matters of clinical judgement the following criteria should be satisfied for ECT Day Patients before they leave the hospital: Session Number Temperature 1 hour post treatment Temperature 3 hour post treatment Pulse Rate (bpm) 1 hour post treatment Pulse Rate (bpm) 3 hour post treatment Blood Pressure 1 hour post treatment Blood Pressure 3 hour post treatment Post treatment observation Respiration 1 hour post treatment Respiration 3 hour post treatment 1. The patient is alert and fully recovered 2. The patient s normal level of mobility has returned 3. The patient is able to tolerate diet and fluids 4. The patient is in the care of a responsible adult 5. The patient and carer have been given and understand the ECT Out Patients Treatment Instructions leaflet 6. The patient and carer have a contact number to call in case of any problems or concerns Nurse initials Page 40 of 65

33 16b. ECT Day Patient Advice Form Patient Name :. I confirm that I have been advised that as a day patient receiving ECT that I (16c pg 28 care pathway): Should not drive, operate machinery, drink alcohol or sign legal documents for at minimum of 24 hours following treatment and I will seek the advice of my Clinical Team regarding for further advice re this Should be accompanied home and have supervision by a responsible adult for 24 hours following treatment and I agree to follow / comply with this advice. Please bring this form to your next appointment. Session 1 Signed. (patient)... Name Signed... (responsible adult) Session 2 Signed. (patient)... Name Signed... (responsible adult) Session 3 Signed. (patient)... Name... Signed... (responsible adult)... Session 4 Signed. (patient)... Name Signed... (responsible adult) Session 5 Signed. (patient)... Name Signed... (responsible adult) Session 6 Signed. (patient)...

34 Surname Forename P Number ECT Policy/C/YEL/cm/10/v3.0 Name... Signed... (responsible adult)... Session 7 Signed. (patient)... Name Signed... (responsible adult) Session 8 Signed. (patient)... Name Signed... (responsible adult) Session 9 Signed. (patient)... Name Signed... (responsible adult) Session 10 Signed. (patient)... Name Signed... (responsible adult) Session 11 Signed. (patient)... Name Signed... (responsible adult) Session 12 Signed.. (patient)... Name Signed... (responsible adult) Page 42 of 65

35 Surname Forename P Number 16c. ECT - Out Patient s Treatment Instructions This fact sheet provides additional information for patients receiving ECT as an out-patient. It should be read along with the ECT INFORMATION LEAFLET You have been prescribed a course of ECT as an out-patient. This will take place twice a week on Tuesday and Friday mornings. Each time you will be given a short anaesthetic and it is important that you keep to the following instructions when you come for treatment: 1. DO NOT have anything to eat or drink after midnight on the day before your treatment 2. PLEASE ARRIVE ON Ward at hours on ECT mornings. 3. DO NOT take any tablets before you have ECT. It you are on regular tablets bring them with you, inform the nurse and take them after treatment when you have recovered. 4. Please DO NOT bring any jewellery or valuables into hospital with you. 5. Please ensure that there are NO GRIPS or METAL objects in your hair and DO NOT use hair lacquer. 6. It is best if a relative or friend can drive you to the hospital and take you home again. Unless you are told differently you should be ready to return home by hours or later if it is more convenient to you. 7. You should NOT DRIVE a motor vehicle, operate machinery or SIGN ANY IMPORTANT DOCUMENTS for a minimum of 24 hours after treatment. You should seek the advice of your Consultant, Clinical Team or GP regarding the appropriateness of resuming these actions. 9. You should remain under the supervision of a responsible adult for 24 hours after treatment. If you are worried about the treatment or if you have any queries please do not hesitate to contact staff on Ward, telephone. PLEASE BRING THIS SHEET WITH YOU WHEN YOU COME FOR TREATMENT Your next appointment date: Day Day Page 43 of 65

36 17. Protocol on Maintenance / Continuation ECT 1. Maintenance ECT should only be prescribed by Consultants 2. Maintenance ECT should be re-prescribed every two treatments 3. It is recommended that at each review patients giving consent are reminded that they can withdraw that consent. 4. Typical continuation treatment in a frequently relapsing patient would be to reduce ECT to fortnightly for 3 months, then 3 weekly for 3 months, then monthly for 3 months then to stop and observe for signs of relapse. 5. It is recommended that the patient s memory and other cognitive functions are recorded monthly 4 and 5 are recommendations derived from Electroconvulsive Therapy a Good Practice Statement The Scottish Office 1997 Page 44 of 65

37 Surname Forename P Number 18. Audit Tool To be completed by the referring team after the course has finished Please record by ticking or crossing compliance for each section Please sign, print name and record designation together with any comments at the end of the tool then forward results to Clinical Audit Team, St Georges, Stafford The following have been recorded: Met Not Met 1. The patient s ethnicity 2. The patient s Mental Health Act status 3. A detailed medical history 4. A Mental State Examination 5. An assessment of cognitive functioning and memory 6. A full physical examination including the cardiovascular, respiratory and neurological systems 7. Existing drug regime 8. An assessment of orientation 9. A clear statement on why ECT has been prescribed 10. An indication that the prescription is within NICE guidelines, or the reason for any exception 11. Written evidence that the anaesthetic risk was assessed, e.g. the ASA grade of the patient is identified and assessment made on the basis of this 12. Current medication, drug allergies and any noted drug problems 13. Results from a recent blood test 14. There is written evidence that ECT was given two times a week at most For a typical treatment the following are recorded: 15. The name of the anaesthetic used 16. The dose of the anaesthetic used 17. The name of the muscle relaxant 18. The dose of the muscle relaxant 19. The current delivered 20. The quality and duration of seizure including whether it was bilateral or unilateral 21. Cardio respiratory changes 22. Post-procedural problems 23. Immediate side effects 24. An assessment of the patient s overall health, e.g. blood pressure, pulse, respiration Met Not Met Page 45 of 65

38 25. Clinical status / symptomatic response 26. Orientation 27. Non-cognitive side effects 28. The patient s cognitive functioning 29. Both the patient s subjective experience of treatment side effects and objective cognitive side effects At the end of a course of treatment: 30. The patient has a clinical interview to establish any autobiographical memory loss, and this is documented For patients that consented to ECT: 31. There is a signed consent form Met Met Met Not Met Not Met Only complete questions 31 to 41 for informal patients The consent form covers the following areas: 32. The maximum number of treatments in the course 33. If the course was for bilateral or unilateral treatment 34. Confirmation that the psychiatrist or nominated deputy has explained the procedure to the patient 35. Confirmation that the psychiatrist or nominated deputy has explained the intended benefits and risks of the procedure 36. Confirmation that the psychiatrist or nominated deputy has discussed with the patient alternative available treatments (including no treatment) 37. Confirmation that the psychiatrist or nominated deputy has discussed the benefits and side effects of alternative treatment 38. That written information had been provided to the patient 39. What procedures the treatment would involve e.g. anaesthesia and muscle relaxation 40. A statement from an interpreter where appropriate 41. A section specifying whether the patient continued to consent before each treatment Patients who were not able to give consent: 42. For patients detained under Mental Health Legislation, the relevant Mental Health Act documents were attached Met Met Not Met Not Met

39 Surname Forename P Number For Day Patients Before treatment commences, day patients and / or their carers sign a form which confirms: Met Not Met 43. They will be accompanied home 44. They will have appropriate supervision by a responsible adult for each night / or 24 hours after ECT treatment 45. They will not drive or operate machinery for a least the next 24 hours 46. They will not drink alcohol for a least the next 24 hours 47. They will not sign any legal documents for a least the next 24 hours 48. If you have any comments regarding any aspect of the audit, please use the box below: Name of Auditor (please print) Signature of Auditor Team Location of completion Forward Results to: Clinical Audit Team, St Georges Hospital, Stafford Page 47 of 65

40 ELECTROCONVULSIVE THERAPY (ECT) Page 48 of 65

South Staffordshire and Shropshire Healthcare NHS Foundation Trust ECT Care Pathway (prescriber to complete except where otherwise stated)

South Staffordshire and Shropshire Healthcare NHS Foundation Trust ECT Care Pathway (prescriber to complete except where otherwise stated) South Staffordshire and Shropshire Healthcare NHS Foundation Trust ECT Care Pathway (prescriber to complete except where otherwise stated) Patient Name of Birth Patient Number Consultant Pathway Commenced.

More information

Electro-convulsive Therapy (ECT) Your questions answered

Electro-convulsive Therapy (ECT) Your questions answered Electro-convulsive Therapy (ECT) Your questions answered Q A Welcome This leaflet aims to answer some of the questions you may have about Electro-convulsive Therapy (ECT). You may wish to know why ECT

More information

Electroconvulsive Therapy (ECT) Patient Information Leaflet

Electroconvulsive Therapy (ECT) Patient Information Leaflet Further information about the content, reference sources or production of this leaflet can be obtained from the Patient Information Centre. This information can be made available in a range of formats

More information

Electroconvulsive Therapy (ECT) Patient Information Leaflet

Electroconvulsive Therapy (ECT) Patient Information Leaflet Electroconvulsive Therapy (ECT) Patient Information Leaflet Contents Page Introduction 3 What is Electroconvulsive Therapy (ECT)? 3 Why has ECT been recommended? 3 What will happen if I have ECT? 3-4 How

More information

Electroconvulsive Therapy (ECT) Patient Information Leaflet

Electroconvulsive Therapy (ECT) Patient Information Leaflet Electroconvulsive Therapy (ECT) Patient Information Leaflet 2 Contents Page Introduction 3 What is Electroconvulsive Therapy (ECT)? 3 Why has ECT been recommended? 3 What will happen if I have ECT? 3-4

More information

Additional details about you What is your ethnic group? Name of next of kin \ Emergency contact

Additional details about you What is your ethnic group? Name of next of kin \ Emergency contact Thank you for applying to join The Hedges Medical Centre. We would like to gather some information about you and ask that you fill in the following questionnaire. You don t have to supply answers to all

More information

Anaesthesia and pain (Daycase Patient) Patient information Leaflet

Anaesthesia and pain (Daycase Patient) Patient information Leaflet Anaesthesia and pain (Daycase Patient) Patient information Leaflet February 2018 INTRODUCTION Welcome to Tameside Hospital, this leaflet gives basic information to help you prepare for your anaesthetic,

More information

Welcome to Wonersh Surgery. In order for us to provide you with the best medical care please complete this Questionnaire and pass to Reception.

Welcome to Wonersh Surgery. In order for us to provide you with the best medical care please complete this Questionnaire and pass to Reception. PATIENT QUESTIONNAIRE WONERSH SURGERY Welcome to Wonersh Surgery. In order for us to provide you with the best medical care please complete this Questionnaire and pass to Reception. DETAILS ABOUT YOU:

More information

Direct Current Cardioversion (DCCV)

Direct Current Cardioversion (DCCV) PLEASE PRINT WHOLE FORM DOUBLE SIDED ON YELLOW PAPER Patient Information to be retained by patient affix patient label What is a This is a procedure carried out under a brief anaesthetic, which uses a

More information

Laparoscopic radical nephrectomy

Laparoscopic radical nephrectomy PLEASE PRINT WHOLE FORM DOUBLE SIDED ON YELLOW PAPER Patient Information to be retained by patient affix patient label What is a laparoscopic radical nephrectomy? This is a procedure which involves removal

More information

Percutaneous nephrolithotomy (PCNL)

Percutaneous nephrolithotomy (PCNL) PLEASE PRINT WHOLE FORM DOUBLE SIDED ON YELLOW PAPER Patient Information to be retained by patient affix patient label What does this procedure involve? The breakdown and removal of kidney stones using

More information

You and your anaesthetic

You and your anaesthetic You and your anaesthetic Information to help patients prepare for an anaesthetic This leaflet gives basic information to help you prepare for your anaesthetic. It has been written by patients, patient

More information

You and your anaesthetic. Information to help patients prepare for an anaesthetic

You and your anaesthetic. Information to help patients prepare for an anaesthetic You and your anaesthetic Information to help patients prepare for an anaesthetic This leaflet gives basic information to help you prepare for your anaesthetic. It has been written by patients, patient

More information

PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM FERRERI / IELSG PROTOCOL. Patient s first names. Date of birth

PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM FERRERI / IELSG PROTOCOL. Patient s first names. Date of birth Page 1 of 6 FORM FERRERI / IELSG PROTOCOL Patient s surname/family name Patient s first names Date of birth Hospital Name: Guy s Hospital St. Thomas Hospital King s College Hospital Lewisham Hospital NHS

More information

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM ZOLEDRONIC ACID. Patient s first names.

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM ZOLEDRONIC ACID. Patient s first names. Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM ZOLEDRONIC ACID Patient s surname/family name Patient s first names Date of birth NHS number (or other identifier)

More information

Electroconvulsive Therapy (ECT) Patient Guide

Electroconvulsive Therapy (ECT) Patient Guide Electroconvulsive Therapy (ECT) Patient Guide February 2015 This booklet has the information you need to give an informed consent for Electroconvulsive Therapy (ECT). You learn what ECT is, the purpose

More information

Canalplasty / excision of exostoses

Canalplasty / excision of exostoses PLEASE PRINT WHOLE FORM DOUBLE SIDED ON YELLOW PAPER Patient Information to be retained by patient affix patient label What is a canalplasty? A canalplasty is an operation to remove exostoses, which are

More information

You and your anaesthetic Information to help patients prepare for an anaesthetic

You and your anaesthetic Information to help patients prepare for an anaesthetic You and your anaesthetic Information to help patients prepare for an anaesthetic You can find out more from Anaesthesia Explained and www.youranaesthetic.info This leaflet gives basic information to help

More information

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM CYTARABINE (HIGH DOSE)

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM CYTARABINE (HIGH DOSE) Patient identifier/label: Page 1 of 6 CYTARABINE Patient s surname/family name Patient s first names Date of birth Hospital Name: Guy s Hospital St. Thomas Hospital King s College Hospital Lewisham Hospital

More information

You and your anaesthetic

You and your anaesthetic Questions you may like to ask your anaesthetist Q Who will give my anaesthetic? Q Do I have to have a general anaesthetic? Q What type of anaesthetic do you recommend? Q Have you often used this type of

More information

Information about Your Anaesthetic and Pain Control After Surgery

Information about Your Anaesthetic and Pain Control After Surgery Information about Your Anaesthetic and Pain Control After Surgery Information for patients Specialist Support If you require this leaflet in another language, large print or another format, please contact

More information

Patient information. You and Your Anaesthetic Information to help you prepare for anaesthetic. Anaesthesia Directorate PIF 344/ V5

Patient information. You and Your Anaesthetic Information to help you prepare for anaesthetic. Anaesthesia Directorate PIF 344/ V5 Patient information You and Your Anaesthetic Information to help you prepare for anaesthetic Anaesthesia Directorate PIF 344/ V5 Types of anaesthesia Anaesthesia stops you feeling pain and other sensations.

More information

Inguinal hernias may be present from birth but may not become evident until later in life. They are usually more common in men.

Inguinal hernias may be present from birth but may not become evident until later in life. They are usually more common in men. This booklet is designed to give you information about inguinal hernia repair done under general anaesthesia. We hope it will answer some of the questions that you or those who care for you may have at

More information

Having a Bronchoscopy

Having a Bronchoscopy Having a Bronchoscopy Department of Respiratory Medicine 2 Patient Information This leaflet will help you and your family to understand more about bronchoscopy. Please read it and ask any questions you

More information

You and your anaesthetic Information to help patients prepare for an anaesthetic

You and your anaesthetic Information to help patients prepare for an anaesthetic You and your anaesthetic Information to help patients prepare for an anaesthetic You can find out more from Anaesthesia explained and www.youranaesthetic.info This leaflet gives basic information to help

More information

CONSENT FORM UROLOGICAL SURGERY

CONSENT FORM UROLOGICAL SURGERY CONSENT FORM for UROLOGICAL SURGERY (Designed in compliance with consent form 1) PATIENT AGREEMENT TO INVESTIGATION OR TREATMENT Patient Details or pre-printed label Patient s NHS Number or Hospital number

More information

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Ponatinib PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL NAME/STAMP:

More information

Mastoidectomy or combined approach tympanoplasty

Mastoidectomy or combined approach tympanoplasty PLEASE PRINT WHOLE FORM DOUBLE SIDED ON YELLOW PAPER Patient Information to be retained by patient affix patient label What is a cholesteatoma? This is a cyst of skin cells behind your eardrum. As it gets

More information

Patient identifier/label: Page 1 of 7 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM EC-T: EPIRUBICIN / CYCLOPHOSPHAMIDE - DOCETAXEL

Patient identifier/label: Page 1 of 7 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM EC-T: EPIRUBICIN / CYCLOPHOSPHAMIDE - DOCETAXEL Patient identifier/label: Page 1 of 7 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM EC-T: EPIRUBICIN / CYCLOPHOSPHAMIDE - DOCETAXEL Patient s surname/family name Patient s first names Date of birth

More information

Mental Health Commission Rules

Mental Health Commission Rules Mental Health Commission Rules Reference Number: R-S59(2)/01/2006 RULES GOVERNING THE USE OF ELECTRO-CONVULSIVE THERAPY 1 st November 2006 PREAMBLE Section 59 of the Mental Health Act 2001 obliges the

More information

Implantation of an Implantable Cardioverter Defibrillator (ICD)

Implantation of an Implantable Cardioverter Defibrillator (ICD) PLEASE PRINT WHOLE FORM DOUBLE SIDED ON YELLOW PAPER Patient Information to be retained by patient affix patient label What is an Implantable? Your doctor has recommended that you have an Implantable.

More information

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Cisplatin- Capecitabine- Trastuzumab PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier)

More information

Planning for a time when you cannot make decisions for yourself

Planning for a time when you cannot make decisions for yourself Planning for a time when you cannot make decisions for yourself An information leaflet for members of the public Version: October 2013 Introduction The Mental Capacity Act 2005 allows you to plan ahead

More information

Clinical Protocol Documentation for Patients Attending for Exodontia under General Anaesthetic Clinical Records and Patient Information

Clinical Protocol Documentation for Patients Attending for Exodontia under General Anaesthetic Clinical Records and Patient Information Clinical Protocol Documentation for Patients Attending for Exodontia under General Anaesthetic Clinical Records and Patient Information CP:92 [Version:1] Applies to:- Specialist Dental Services Sub Committee

More information

Patient identifier/label: Page 1 of 5 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM BEVACIZUMAB. Patient s first names. Date of birth.

Patient identifier/label: Page 1 of 5 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM BEVACIZUMAB. Patient s first names. Date of birth. Patient identifier/label: Page 1 of 5 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM BEVACIZUMAB Patient s surname/family name Patient s first names Date of birth Hospital Name: NHS number (or other

More information

Assessment of Fitness to Drive to be completed by medical practitioner

Assessment of Fitness to Drive to be completed by medical practitioner COMMERCIAL VEHICLE DRIVER MEDICAL ASSESSMENT This Medical Assessment meets the requirements of the following Western Australian Government Authorities; Department of Commerce, WorkSafe - Occupational Safety

More information

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM CHOP 21 +/- RITUXIMAB. Patient s first names.

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM CHOP 21 +/- RITUXIMAB. Patient s first names. Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM CHOP 21 +/- RITUXIMAB Patient s surname/family name Patient s first names Date of birth Hospital Name: Guy s Hospital

More information

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM CISPLATIN + ETOPOSIDE ORAL/INTRAVENOUS

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM CISPLATIN + ETOPOSIDE ORAL/INTRAVENOUS Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM CISPLATIN + ETOPOSIDE ORAL/INTRAVENOUS Patient s surname/family name Patient s first names Date of birth Hospital

More information

MERSEY CARE NHS TRUST HOW WE MANAGE MEDICINES. MM11 - High-Dose Antipsychotic Use Guidelines (local guideline) KEY ISSUES

MERSEY CARE NHS TRUST HOW WE MANAGE MEDICINES. MM11 - High-Dose Antipsychotic Use Guidelines (local guideline) KEY ISSUES MERSEY CARE NHS TRUST HOW WE MANAGE MEDICINES MM11 - High-Dose Antipsychotic Use Guidelines (local guideline) Medicines Management Services aim to ensure that (i) Service users receive their medicines

More information

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM ABVD. Patient s first names.

Patient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM ABVD. Patient s first names. Patient identifier/label: Page 1 of 6 Patient s surname/family name Patient s first names Date of birth Hospital Name: Guy s Hospital St. Thomas Hospital King s College Hospital Lewisham Hospital NHS number

More information

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Carboplatin-Etoposide PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL

More information

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Axitinib PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL NAME/STAMP:

More information

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: BEP (5 day) PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL NAME/STAMP:

More information

Thrombosis and Anticoagulation Team. Warfarin. Information for patients, relatives and carers

Thrombosis and Anticoagulation Team. Warfarin. Information for patients, relatives and carers Thrombosis and Anticoagulation Team Warfarin Information for patients, relatives and carers What is warfarin? Warfarin is an anticoagulant. Anticoagulants are drugs which prevent harmful blood clots forming

More information

You and your anaesthe c

You and your anaesthe c You and your anaesthe c Information to help patients prepare for an anaesthetic This leaflet gives basic information to help you prepare for your anaesthetic. Some types of anaesthesia Anaesthesia stops

More information

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Oxaliplatin- Fluorouracil (FOLFOX) PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier)

More information

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Nintedanib-Docetaxel PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL

More information

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Atezolizumab PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL NAME/STAMP:

More information

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Gemcitabine- Carboplatin PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL

More information

Patient identifier/label: Page 1 of 5 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM CABOZANTINIB. Patient s first names.

Patient identifier/label: Page 1 of 5 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM CABOZANTINIB. Patient s first names. Patient identifier/label: Page 1 of 5 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM CABOZANTINIB Patient s surname/family name Patient s first names Date of birth Hospital Name: NHS number (or other

More information

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Irinotecan- Capecitabine (CAPIRI) PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier)

More information

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Pembrolizumab PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL NAME/STAMP:

More information

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Zoledronic acid PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL NAME/STAMP:

More information

Diagnostic and therapeutic pleural aspiration

Diagnostic and therapeutic pleural aspiration PLEASE PRINT WHOLE FORM DOUBLE SIDED ON YELLOW PAPER Patient Information to be retained by patient Diagnostic and therapeutic pleural aspiration affix patient label Who is this leaflet for? This leaflet

More information

Fractured neck of femur

Fractured neck of femur PLEASE PRINT WHOLE FORM DOUBLE SIDED ON YELLOW PAPER Patient Information to be retained by patient affix patient label What is a fractured neck of femur? A healthy hip joint is vital to normal walking

More information

ECT Referral Patient information

ECT Referral Patient information ECT Referral Patient information of Assessment Telephone Number Ethnic Origin First Treatment Treatment Site (please tick) Male Female Antelope Hse Elmleigh Parklands St. James Responsible Clinician Referred

More information

Transperineal ultrasound-guided biopsy of the prostate gland

Transperineal ultrasound-guided biopsy of the prostate gland PLEASE PRINT WHOLE FORM DOUBLE SIDED ON YELLOW PAPER Patient Information to be retained by patient biopsy of the prostate gland affix patient label What is a transperineal (TP) ultrasound-guided prostate

More information

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Docetaxel-Oxaliplatin- Fluorouracil (FLOT) PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other

More information

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Dabrafenib-Trametinib PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL

More information

About general anaesthesia Day Surgery Unit Patient Information Leaflet

About general anaesthesia Day Surgery Unit Patient Information Leaflet About general anaesthesia Day Surgery Unit Patient Information Leaflet Originator: Nahla Farid - Consultant Anaesthetist Date: November 2011 Version: 1 Date for Review: November 2014 DGOH Ref No: DGOH/PIL/00560

More information

Chemotherapy Suite: Ward [Mon - Fri 2pm - 4pm] Your oncologist s secretary:...

Chemotherapy Suite: Ward [Mon - Fri 2pm - 4pm] Your oncologist s secretary:... Coping, now your chemotherapy is finishing [ovarian cancer] Patient Information Series PI 41a East and North Hertfordshire NHS Trust 2 Contacts Chemotherapy Suite:... 020 3826 2236 [Mon - Fri, 8.00am -

More information

Fitting of an Intrauterine Device (IUD)

Fitting of an Intrauterine Device (IUD) PLEASE PRINT WHOLE FORM DOUBLE SIDED ON YELLOW PAPER Patient Information to be retained by patient affix patient label What is an IUD? An IUD is a small T-shaped plastic and copper device that is put into

More information

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: FEC-P PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL NAME/STAMP: MALE

More information

Percutaneous coronary intervention (angioplasty) +/- rotablation

Percutaneous coronary intervention (angioplasty) +/- rotablation PLEASE PRINT WHOLE FORM DOUBLE SIDED ON YELLOW PAPER Patient Information to be retained by patient affix patient label Why do I need this procedure? If you are coming into hospital for a cardiac procedure

More information

Electroconvulsive Therapy (ECT)

Electroconvulsive Therapy (ECT) Electroconvulsive Therapy (ECT) UHN Information for patients and families Read this booklet to learn: What ECT is and how it works How to prepare for the treatment What you can expect Some side effects

More information

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Pazopanib PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL NAME/STAMP:

More information

Pilonidal Sinus. Whiston Hospital Warrington Road, Prescot, Merseyside, L35 5DR Telephone:

Pilonidal Sinus. Whiston Hospital Warrington Road, Prescot, Merseyside, L35 5DR Telephone: Pilonidal Sinus Whiston Hospital Warrington Road, Prescot, Merseyside, L35 5DR Telephone: 0151 426 1600 Author: General Surgery Department: Colorectal Document Number: STHK1059 Version: 002 Review date:

More information

Intranet version. Bradford Teaching Hospitals. NHS Foundation Trust. Having a Gastroscopy. Gastroenterology Unit patient information booklet

Intranet version. Bradford Teaching Hospitals. NHS Foundation Trust. Having a Gastroscopy. Gastroenterology Unit patient information booklet Intranet version Bradford Teaching Hospitals NHS Foundation Trust Having a Gastroscopy Gastroenterology Unit patient information booklet What is a gastroscopy? Gastroscopy is a procedure that allows us

More information

Total knee replacement

Total knee replacement PLEASE PRINT WHOLE FORM DOUBLE SIDED ON YELLOW PAPER Patient Information to be retained by patient affix patient label What is a total knee replacement? In a total knee replacement the cartilage surfaces

More information

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Docetaxel-EC PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL NAME/STAMP:

More information

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Everolimus PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL NAME/STAMP:

More information

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Niraparib PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL NAME/STAMP:

More information

Having an MRI Scan of the Small Bowel (MRI Enterogram)

Having an MRI Scan of the Small Bowel (MRI Enterogram) Having an MRI Scan of the Small Bowel (MRI Enterogram) Department of Radiology Information for Patients i Radiology Leaflet No. 73 Contents Page number Introduction 3 What is an MRI scan? 3 Information

More information

APPLICATION FOR PODIATRY ASSESSMENT

APPLICATION FOR PODIATRY ASSESSMENT Office Only Date Received. TIARA No:.. Triaged: Routine / Urgent Clinic:.. Appointment date: Community Health Services Please Return To: Podiatry Service Call Centre South Wigston Health Centre 80 Blaby

More information

Laparoscopic Cholecystectomy

Laparoscopic Cholecystectomy Treatment Centre Laparoscopic Cholecystectomy What is a laparoscopic cholecystectomy? You need this operation because stones have collected in your gallbladder (the area where a small amount of bile is

More information

ECT and the law. Dr Hugh Series. Consultant old age psychiatrist, Oxford Health NHS FT Member, Law Faculty, University of Oxford

ECT and the law. Dr Hugh Series. Consultant old age psychiatrist, Oxford Health NHS FT Member, Law Faculty, University of Oxford ECT and the law Dr Hugh Series Consultant old age psychiatrist, Oxford Health NHS FT Member, Law Faculty, University of Oxford Outline Assault Mental health law in E&W MHA ECT in general hospital MCA DOLS

More information

The treatment of bipolar disorder in adults, children and adolescents

The treatment of bipolar disorder in adults, children and adolescents DRAFT FOR CONSULTATION The treatment of bipolar disorder in adults, children and adolescents The paragraphs in the draft are numbered for the purposes of consultation. The final version will not contain

More information

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Bevacizumab + Chemotherapy PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL

More information

SMOKING CESSATION STUDY SERVICE USER INFORMATION SHEET. Thank you! Information about our research and invitation to take part in our study

SMOKING CESSATION STUDY SERVICE USER INFORMATION SHEET. Thank you! Information about our research and invitation to take part in our study believe that this study is safe and do not expect you to suffer any harm or injury because of your participation in it. However, Queen Mary University of London has agreed that if you are harmed as a result

More information

Patient information and consent to flexible cystoscopy

Patient information and consent to flexible cystoscopy Patient information and consent to flexible cystoscopy Key messages for patients Please read this information carefully, you and your healthcare professional will sign it to document your consent. It is

More information

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Cabozantinib PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL NAME/STAMP:

More information

The pillars defining our quality care. We Care!

The pillars defining our quality care. We Care! The pillars defining our quality care We Care! 1 What is Anaesthesia? Anaesthesia stops you feeling pain and other sensations. It can be given in various ways and does not always make you unconscious.

More information

The use of electroconvulsive therapy

The use of electroconvulsive therapy NHS National Institute for Clinical Excellence The use of electroconvulsive therapy Understanding NICE guidance information for service users, their advocates and carers, and the public April 2003 The

More information

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Sunitinib PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL NAME/STAMP:

More information

Having a kidney biopsy. Information for patients Sheffield Kidney Institute (Renal Unit)

Having a kidney biopsy. Information for patients Sheffield Kidney Institute (Renal Unit) Having a kidney biopsy Information for patients Sheffield Kidney Institute (Renal Unit) This leaflet is designed to answer any questions you may have about having a biopsy of your kidney. We hope that

More information

Prescribing Framework for Galantamine in the Treatment and Management of Dementia

Prescribing Framework for Galantamine in the Treatment and Management of Dementia Hull & East Riding Prescribing Committee Prescribing Framework for Galantamine in the Treatment and Management of Dementia Patients Name:.. NHS Number: Patients Address:... (Use addressograph sticker)

More information

INFORMATION SHEET FOR THE DEPARTMENT OF PAIN AND PALLIATIVE CARE

INFORMATION SHEET FOR THE DEPARTMENT OF PAIN AND PALLIATIVE CARE INFORMATION SHEET FOR THE DEPARTMENT OF PAIN AND PALLIATIVE CARE Please review the following instructions as it contains important information regarding the management of your pain. Once reviewed, our

More information

Patient's surname/family name. Patient's first names. Date of birth. Responsible health professional. Job title. NHS number (or other identifier)

Patient's surname/family name. Patient's first names. Date of birth. Responsible health professional. Job title. NHS number (or other identifier) Page 1 of7 Patient's surname/family name Department of Health THE ROYAL MARSDEN NHS FOUNDATION TRUST Robotic-assisted Laparoscopic Prostatectomy (RALP) Patient Agreement to Investigation or Treatment Patient's

More information

Having an Anaesthetic Your Questions Answered

Having an Anaesthetic Your Questions Answered PATIENT INFORMATION Having an Anaesthetic Your Questions Answered This leaflet explains what you can expect when having an anaesthetic for a planned operation. What is anaesthesia? Anaesthesia means loss

More information

Mental capacity and mental illness

Mental capacity and mental illness Mental capacity and mental illness The Mental Capacity Act 2005 (MCA) Mental capacity is the ability to make your own decisions. If you lose mental capacity the Mental Capacity Act 2005 (MCA) protects

More information

Unit 5 MCA & DOLS. Deprivation of Liberty Safeguards (DOLS) Lasting Powers of Attorneys (LPAs) Advance Decisions to Refuse Treatment (ADRTs)

Unit 5 MCA & DOLS. Deprivation of Liberty Safeguards (DOLS) Lasting Powers of Attorneys (LPAs) Advance Decisions to Refuse Treatment (ADRTs) Unit 5 MCA & DOLS Unit 5 MCA & DOLS INTRODUCTION The Mental Capacity Act 2005 covering England and Wales provides a statutory framework for people who lack capacity to make decisions for themselves, or

More information

Essential Shared Care Agreement: Lithium

Essential Shared Care Agreement: Lithium Ref No. E042 Essential Shared Care Agreement: Lithium Please complete the following details: Patient s name, address, date of birth Treatment (indication, dose regimen, brand name) Monitoring (proposed

More information

Squint surgery in adults

Squint surgery in adults Squint surgery in adults Eye Department Patient information leaflet What is the aim of surgery? The main aim of squint surgery is to improve the alignment of the eyes so that the squint is less noticeable.

More information

three times more likely to need an organ transplant

three times more likely to need an organ transplant Black people are three times more likely to need an organ transplant But less than 1% of people on the NHS Organ Donor Register are from our community. If more people registered as donors, more lives could

More information

Initiation of Clozapine Treatment Community Patients

Initiation of Clozapine Treatment Community Patients Initiation of Clozapine Treatment Community Patients Who Should Read This Policy Target Audience All clinical staff working in the community N/A N/A Initiation of Clozapine Treatment for Patients in the

More information